[Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Revista Española de Cardiología

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1885-5857(09)71512-9PMID 19150013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Percutaneous intervention on the saphenous vein bypass grafts—Long‐term outcomes

  2008cited by this paper
• Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.

  2008cited by this paper
• [Spanish Cardiac Catheterization and Coronary Intervention Registry. 16th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2006)].

  2007cited by this paper
• Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.

  2007cited by this paper
• Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.

  2007cited by this paper
• "Crying fire in a theater" or a "confirmatory sighting?".

  2007cited by this paper
• Registro Español de Hemodinámica y Cardiología Intervencionista. XVI Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2006)

  2007cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention

  2006cited by this paper
• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cited by this paper
• Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.

  2006cited by this paper
• Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.

  2006cited by this paper
• ACC/AHA/SCAI Practice Guidelines, February 21, 2006

  2006cited by this paper
• Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study

  2006cited by this paper
• Drug‐eluting stenting is superior to bare metal stenting in saphenous vein grafts

  2005cited by this paper
• Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.

  2005cited by this paper
• [Direct stenting in saphenous vein grafts. Immediate and long-term results].

  2005cited by this paper
• Clinical outcomes after sirolimus‐eluting stent implantation for de novo saphenous vein graft lesions

  2005cited by this paper
• [Guidelines for percutaneous coronary interventions].

  2005cited by this paper
• Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

  2005cited by this paper
• Implante de stent directo en puentes de safena. Resultados inmediatos y a largo plazo

  2005cited by this paper
• Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.

  2005cited by this paper
• Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease.

  2004cited by this paper
• Percutaneous treatment of saphenous vein graft disease: the ongoing challenge.

  2003cited by this paper
• Vessel caliber and restenosis: A prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient

  2003cited by this paper
• A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

  2002cited by this paper
• A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION

  2002cited by this paper
• Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials

  2002cited by this paper
• Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty.

  2000cited by this paper
• Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts.

  1998cited by this paper
• Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty.

  1997cited by this paper
• Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.

  1997cited by this paper
• Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation.

  1994cited by this paper
• Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting: ten years' experience.

  1994cited by this paper
• Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).

  1993cited by this paper
• Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass.

  1990cited by this paper

• Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.

  2016cites this paper
• Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting.

  2015cites this paper
• Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.

  2014cites this paper
• Long‐term outcome following percutaneous coronary intervention with drug‐eluting stents compared with bare‐metal stents in saphenous vein graft lesions: From Western Denmark heart registry

  2014cites this paper
• [Update in interventional cardiology].

  2013cites this paper
• Drug-Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Intervention.

  2013cites this paper
• Percutaneous revascularization strategies in saphenous vein graft lesions: long-term results.

  2012cites this paper
• In‐Hospital and 1‐year outcomes with drug‐eluting versus bare metal stents in saphenous vein graft intervention: A report from the EVENT registry

  2012cites this paper
• Interventions: A Systematic Review and Meta-Analysis Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft

  2012cites this paper
• Coronary stenting with MGuard: extended follow-up of first human trial.

  2011cites this paper
• Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: A comprehensive meta‐analysis of randomized trials and observational studies comprising 7,994 patients

  2011cites this paper
• A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis.

  2011cites this paper
• Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.

  2011cites this paper
• [Update on interventional cardiology].

  2010cites this paper
• Drug-Eluting or Bare Metal Stents for the Treatment of Saphenous Vein Graft Disease: A Bayesian Meta-Analysis

  2010cites this paper
• Drug-eluting stents in saphenous vein graft interventions: a systematic review.

  2010cites this paper
• Can we improve outcomes in patients with previous coronary artery bypass surgery admitted for acute coronary syndrome?

  2010cites this paper
• Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis.

  2010cites this paper
• Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis.

  2010cites this paper
• Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis

  2010cites this paper
• Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.

  2010cites this paper
• Vessel diameter should be taken into account in saphenous stenting.

  2010cites this paper
• Advances in vein graft intervention

  2010cites this paper
• Valor pronstico de la tasa de filtracin glomerular al ao del trasplante cardiaco

  2010cites this paper
• Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.

  2010cites this paper
• Podemos mejorar la evolución de los pacientes con antecedentes de cirugía de bypass coronario ingresados por un síndrome coronario agudo

  2010cites this paper
• Drug-eluting versus bare-metal stents for treating saphenous vein grafts.

  2009cites this paper
• Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.

  2009cites this paper
• Stent implantation in saphenous vein grafts.

  2009cites this paper
• READER'S COMMENTS

  2009cites this paper
• Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?

  2009cites this paper
• rug-Eluting Stents Versus Bare-Metal Stents n Saphenous Vein Graft Interventions

  year unknowncites this paper